BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,092 | -20.5% | 21,737 | +0.1% | 0.06% | -14.5% |
| Q2 2023 | $1,373 | +21.9% | 21,717 | -13.2% | 0.07% | +38.0% |
| Q1 2023 | $1,126 | +2.7% | 25,020 | +0.1% | 0.05% | -5.7% |
| Q4 2022 | $1,096 | -99.9% | 25,006 | -0.3% | 0.05% | -33.8% |
| Q3 2022 | $1,654,000 | +9.4% | 25,085 | -16.2% | 0.08% | +21.2% |
| Q2 2022 | $1,512,000 | -32.7% | 29,946 | -14.8% | 0.07% | -25.0% |
| Q1 2022 | $2,245,000 | -46.3% | 35,146 | -9.9% | 0.09% | -31.8% |
| Q4 2021 | $4,181,000 | -24.6% | 39,029 | -27.7% | 0.13% | -27.9% |
| Q3 2021 | $5,548,000 | +18.0% | 53,954 | +1.0% | 0.18% | +14.0% |
| Q2 2021 | $4,702,000 | +1549.8% | 53,433 | +394.1% | 0.16% | +1862.5% |
| Q4 2015 | $285,000 | +126.2% | 10,815 | +83.3% | 0.01% | +100.0% |
| Q3 2015 | $126,000 | -17.6% | 5,900 | +1.7% | 0.00% | -20.0% |
| Q2 2015 | $153,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |